Assessing the association between leptin and bone mineral density in HIV-infected men

Madhu N. Rao, Morris Schambelan, Viva W. Tai, Donald I. Abrams, Hootan Khatami, Peter J Havel, Giorgos Sakkas, Kathleen Mulligan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

HIV-infected individuals are at risk for decreased bone mineral density (BMD). The known risk factors for bone loss do not fully explain the increased risk in this population. There is emerging evidence that leptin, a hormone secreted by adipocytes, plays an important role in bone metabolism. Several studies have assessed the relationship between leptin and bone density in healthy adults, but there are few such studies in HIV-infected individuals. Furthermore, HIV infected individuals on antiretroviral therapy are at increased risk for altered fat distribution, which may impact the relationship between leptin and BMD. In a cross-sectional analysis of data in 107 HIV-infected men, we determined whether serum leptin levels were associated with whole-body BMD and bone mineral content measured by dual-energy X-ray absorptiometry (DEXA), after adjusting for confounders including body fat distribution. We found an inverse association between leptin and bone density in those with peripheral lipoatrophy, defined objectively as <3 kg appendicular fat by DEXA, but no such relationship was seen in those with >3 kg appendicular fat. This result suggests that fat distribution may modify the relationship between leptin and bone density.

Original languageEnglish (US)
Article number103072
JournalAIDS Research and Treatment
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Leptin
Bone Density
HIV
Fats
Bone and Bones
Body Fat Distribution
Photon Absorptiometry
Adipocytes
Cross-Sectional Studies
Hormones
Serum
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology and Allergy
  • Infectious Diseases
  • Dermatology

Cite this

Rao, M. N., Schambelan, M., Tai, V. W., Abrams, D. I., Khatami, H., Havel, P. J., ... Mulligan, K. (2012). Assessing the association between leptin and bone mineral density in HIV-infected men. AIDS Research and Treatment, 2012, [103072]. https://doi.org/10.1155/2012/103072

Assessing the association between leptin and bone mineral density in HIV-infected men. / Rao, Madhu N.; Schambelan, Morris; Tai, Viva W.; Abrams, Donald I.; Khatami, Hootan; Havel, Peter J; Sakkas, Giorgos; Mulligan, Kathleen.

In: AIDS Research and Treatment, Vol. 2012, 103072, 2012.

Research output: Contribution to journalArticle

Rao, MN, Schambelan, M, Tai, VW, Abrams, DI, Khatami, H, Havel, PJ, Sakkas, G & Mulligan, K 2012, 'Assessing the association between leptin and bone mineral density in HIV-infected men', AIDS Research and Treatment, vol. 2012, 103072. https://doi.org/10.1155/2012/103072
Rao, Madhu N. ; Schambelan, Morris ; Tai, Viva W. ; Abrams, Donald I. ; Khatami, Hootan ; Havel, Peter J ; Sakkas, Giorgos ; Mulligan, Kathleen. / Assessing the association between leptin and bone mineral density in HIV-infected men. In: AIDS Research and Treatment. 2012 ; Vol. 2012.
@article{ba26610f91204b2bb9686b8a8257b38e,
title = "Assessing the association between leptin and bone mineral density in HIV-infected men",
abstract = "HIV-infected individuals are at risk for decreased bone mineral density (BMD). The known risk factors for bone loss do not fully explain the increased risk in this population. There is emerging evidence that leptin, a hormone secreted by adipocytes, plays an important role in bone metabolism. Several studies have assessed the relationship between leptin and bone density in healthy adults, but there are few such studies in HIV-infected individuals. Furthermore, HIV infected individuals on antiretroviral therapy are at increased risk for altered fat distribution, which may impact the relationship between leptin and BMD. In a cross-sectional analysis of data in 107 HIV-infected men, we determined whether serum leptin levels were associated with whole-body BMD and bone mineral content measured by dual-energy X-ray absorptiometry (DEXA), after adjusting for confounders including body fat distribution. We found an inverse association between leptin and bone density in those with peripheral lipoatrophy, defined objectively as <3 kg appendicular fat by DEXA, but no such relationship was seen in those with >3 kg appendicular fat. This result suggests that fat distribution may modify the relationship between leptin and bone density.",
author = "Rao, {Madhu N.} and Morris Schambelan and Tai, {Viva W.} and Abrams, {Donald I.} and Hootan Khatami and Havel, {Peter J} and Giorgos Sakkas and Kathleen Mulligan",
year = "2012",
doi = "10.1155/2012/103072",
language = "English (US)",
volume = "2012",
journal = "AIDS Research and Treatment",
issn = "2090-1240",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Assessing the association between leptin and bone mineral density in HIV-infected men

AU - Rao, Madhu N.

AU - Schambelan, Morris

AU - Tai, Viva W.

AU - Abrams, Donald I.

AU - Khatami, Hootan

AU - Havel, Peter J

AU - Sakkas, Giorgos

AU - Mulligan, Kathleen

PY - 2012

Y1 - 2012

N2 - HIV-infected individuals are at risk for decreased bone mineral density (BMD). The known risk factors for bone loss do not fully explain the increased risk in this population. There is emerging evidence that leptin, a hormone secreted by adipocytes, plays an important role in bone metabolism. Several studies have assessed the relationship between leptin and bone density in healthy adults, but there are few such studies in HIV-infected individuals. Furthermore, HIV infected individuals on antiretroviral therapy are at increased risk for altered fat distribution, which may impact the relationship between leptin and BMD. In a cross-sectional analysis of data in 107 HIV-infected men, we determined whether serum leptin levels were associated with whole-body BMD and bone mineral content measured by dual-energy X-ray absorptiometry (DEXA), after adjusting for confounders including body fat distribution. We found an inverse association between leptin and bone density in those with peripheral lipoatrophy, defined objectively as <3 kg appendicular fat by DEXA, but no such relationship was seen in those with >3 kg appendicular fat. This result suggests that fat distribution may modify the relationship between leptin and bone density.

AB - HIV-infected individuals are at risk for decreased bone mineral density (BMD). The known risk factors for bone loss do not fully explain the increased risk in this population. There is emerging evidence that leptin, a hormone secreted by adipocytes, plays an important role in bone metabolism. Several studies have assessed the relationship between leptin and bone density in healthy adults, but there are few such studies in HIV-infected individuals. Furthermore, HIV infected individuals on antiretroviral therapy are at increased risk for altered fat distribution, which may impact the relationship between leptin and BMD. In a cross-sectional analysis of data in 107 HIV-infected men, we determined whether serum leptin levels were associated with whole-body BMD and bone mineral content measured by dual-energy X-ray absorptiometry (DEXA), after adjusting for confounders including body fat distribution. We found an inverse association between leptin and bone density in those with peripheral lipoatrophy, defined objectively as <3 kg appendicular fat by DEXA, but no such relationship was seen in those with >3 kg appendicular fat. This result suggests that fat distribution may modify the relationship between leptin and bone density.

UR - http://www.scopus.com/inward/record.url?scp=84873831521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873831521&partnerID=8YFLogxK

U2 - 10.1155/2012/103072

DO - 10.1155/2012/103072

M3 - Article

VL - 2012

JO - AIDS Research and Treatment

JF - AIDS Research and Treatment

SN - 2090-1240

M1 - 103072

ER -